Join +750K new investors every month who copy stock picks from billionaire's portfoliosSign Up Free

Veeva Systems To Improve Patient Outcome With Crossix Buyout

Published 10/01/2019, 09:14 PM
Updated 07/09/2023, 06:31 AM
MCK
-
MDRX
-
CERN
-
VEEV
-

Veeva Systems Inc. (NYSE:VEEV) recently inked a deal to acquire Crossix Solutions. The buyout is likely to enable the company enhance its cloud-based software technology. Moreover, the deal reinforces Veeva Systems’ presence in the healthcare IT (HCIT) space.

Notably, Crossix — a pioneer in privacy-safe patient data and analytics — will continue to operate as an independent business unit.

Financial Details of the Acquisition

Veeva Systems is set to acquire Crossix for a purchase price of $430 million in an all-cash transaction. Additionally, few employees of Crossix will receive long-term equity retention grants amounting to about $120 million in total. The buyout is anticipated to get completed in November this year.

Deal Rationale

Veeva Systems is likely to leverage Crossix’s analytics platform, which connects health and non-health data for more than 300 million U.S. patients, and provide improved patient outcomes. The buyout is the right step forward for Veeva Systems as it will take the company closer to its goal of a patient-centric healthcare system.

Moreover, the company’s cloud-based software technology is likely to get a boost on the back of this buyout.

Veeva’s Cloud-Based Software Technology Update

Veeva Systems recently released its advanced Veeva Commercial Cloud offering, Veeva CRM Engage Webinar, at the Veeva Commercial Summit Europe. The company also released Veeva Vault PromoMats Brand Portal — a new digital asset management capability that helps brand managers create portals, organize and showcase content within Veeva Vault PromoMats.

Market Holds Promise

Per a report by Medgadget, the Global Healthcare Analytics market is valued at $20.86 billion and is estimated to hit $108.01 billion by 2025 at a CAGR of 26.5% from 201-2025. Increasing pressure on the healthcare providers to boost the efficiency of healthcare and improvement in the patient’s outcome is expected to fuel market growth.

Some other key players who have showed substantial progress in the healthcare analytics space are Cerner Corporation (NASDAQ:CERN) , Allscripts Healthcare Solutions Inc. (NASDAQ:MDRX) and McKesson Corporation (NYSE:MCK) .

Cerner is one of the largest pure-play HCIT companies and its broad presence, large reference-able client base and composite array of solutions make it an ideal candidate for investors seeking an exposure to the HCIT industry.

Allscripts Healthcare provides information technology (IT) solutions and services to healthcare organizations. Moreover, Allscripts Sunrise is a fully integrated Electronic Health Record (HER) platform that connects all clinical and financial aspects of a hospital or health system for inpatient, emergency and outpatient care.

McKesson is a health care services and information technology company. Following a merger agreement with Change Healthcare Holdings, which is a leading provider of software and analytics, network solutions and technology-enabled services, McKesson formed a new healthcare information technology company called Change Healthcare. The new company aspires to be a better healthcare system on the back of a broad set of complementary capabilities that will deliver wide-ranging financial, operational and clinical benefits to payers, providers and consumers.

7 Best Stocks for the Next 30 Days

Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers “Most Likely for Early Price Pops.”

Since 1988, the full list has beaten the market more than 2X over with an average gain of +24.6% per year. So be sure to give these hand-picked 7 your immediate attention.

See them now >>



Veeva Systems Inc. (VEEV): Free Stock Analysis Report

Allscripts Healthcare Solutions, Inc. (MDRX): Free Stock Analysis Report

Cerner Corporation (CERN): Free Stock Analysis Report

McKesson Corporation (MCK): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.